Diabetes drug trial aims to stop colon cancer before it starts
NCT ID NCT07095517
Summary
This early-stage study is testing whether tirzepatide, a medication used for diabetes and weight loss, might help prevent colorectal cancer in younger adults. Researchers will give the weekly injection to 20 participants aged 18-50 who have had precancerous colon polyps removed. They will collect blood, urine, and stool samples to look for biological signs that the drug is reducing cancer risk.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital Cancer Center
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.